Business Description
Becton, Dickinson and Co
NAICS : 339112
SIC : 3841
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Compare
Compare
Traded in other countries / regions
BDX.Austria
•
B1DX34.Brazil
•
BOX.Germany
•
BDX.Mexico
•
BDX-RM.Russia
•
BDX.Switzerland
•
0R19.UK
•
BDX.USA
Description
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.16 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.64 | |||||
| Debt-to-EBITDA | 3.24 | |||||
| Interest Coverage | 7.57 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.67 | |||||
| Beneish M-Score | -2.46 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.7 | |||||
| 3-Year EBITDA Growth Rate | 5.4 | |||||
| 3-Year EPS without NRI Growth Rate | 125.2 | |||||
| 3-Year FCF Growth Rate | 16.2 | |||||
| 3-Year Book Growth Rate | 2.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 5.7 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 2.48 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 87.16 | |||||
| 9-Day RSI | 81.05 | |||||
| 14-Day RSI | 74.91 | |||||
| 6-1 Month Momentum % | 2.62 | |||||
| 12-1 Month Momentum % | 15.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.35 | |||||
| Quick Ratio | 0.9 | |||||
| Cash Ratio | 0.36 | |||||
| Days Inventory | 101.93 | |||||
| Days Sales Outstanding | 39.92 | |||||
| Days Payable | 59.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.18 | |||||
| Dividend Payout Ratio | 0.52 | |||||
| 3-Year Dividend Growth Rate | 3.4 | |||||
| Forward Dividend Yield % | 1.29 | |||||
| 5-Year Yield-on-Cost % | 1.44 | |||||
| 3-Year Average Share Buyback Ratio | -2 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.95 | |||||
| Operating Margin % | 15.11 | |||||
| Net Margin % | 8.52 | |||||
| ROE % | 6.83 | |||||
| ROA % | 3.26 | |||||
| ROIC % | 6.19 | |||||
| ROC (Joel Greenblatt) % | 38.49 | |||||
| ROCE % | 5.92 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 46.17 | |||||
| Forward PE Ratio | 21.32 | |||||
| PE Ratio without NRI | 45.39 | |||||
| Shiller PE Ratio | 50.08 | |||||
| Price-to-Owner-Earnings | 47.64 | |||||
| PEG Ratio | 6.98 | |||||
| PS Ratio | 3.74 | |||||
| PB Ratio | 3 | |||||
| Price-to-Free-Cash-Flow | 52.55 | |||||
| Price-to-Operating-Cash-Flow | 29.49 | |||||
| EV-to-EBIT | 32.44 | |||||
| EV-to-Forward-EBIT | 28.43 | |||||
| EV-to-EBITDA | 17.85 | |||||
| EV-to-Forward-EBITDA | 16.73 | |||||
| EV-to-Revenue | 4.37 | |||||
| EV-to-Forward-Revenue | 4.52 | |||||
| EV-to-FCF | 61.5 | |||||
| Price-to-Projected-FCF | 1.65 | |||||
| Price-to-DCF (Earnings Based) | 3.66 | |||||
| Price-to-DCF (FCF Based) | 3.12 | |||||
| Price-to-Median-PS-Value | 1.1 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.53 | |||||
| Earnings Yield (Greenblatt) % | 3.08 | |||||
| Forward Rate of Return (Yacktman) % | 13.23 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 18,432.049 | ||
| EPS (TTM) (€) | 5.21 | ||
| Beta | 0.09 | ||
| Volatility % | 10.36 | ||
| 14-Day RSI | 74.91 | ||
| 14-Day ATR (€) | 3.288819 | ||
| 20-Day SMA (€) | 245.06 | ||
| 12-1 Month Momentum % | 15.34 | ||
| 52-Week Range (€) | 197.50471 - 262.9 | ||
| Shares Outstanding (Mil) | 285.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Becton, Dickinson and Co Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||